BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30158928)

  • 1. Human Surfactant Protein D Suppresses Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells by Downregulating TGF-β.
    Kaur A; Riaz MS; Singh SK; Kishore U
    Front Immunol; 2018; 9():1844. PubMed ID: 30158928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recombinant Fragment of Human Surfactant Protein D induces Apoptosis in Pancreatic Cancer Cell Lines
    Kaur A; Riaz MS; Murugaiah V; Varghese PM; Singh SK; Kishore U
    Front Immunol; 2018; 9():1126. PubMed ID: 29915574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer.
    Wu Y; Sato F; Yamada T; Bhawal UK; Kawamoto T; Fujimoto K; Noshiro M; Seino H; Morohashi S; Hakamada K; Abiko Y; Kato Y; Kijima H
    Int J Oncol; 2012 Oct; 41(4):1337-46. PubMed ID: 22825629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells.
    Murugaiah V; Agostinis C; Varghese PM; Belmonte B; Vieni S; Alaql FA; Alrokayan SH; Khan HA; Kaur A; Roberts T; Madan T; Bulla R; Kishore U
    Front Immunol; 2020; 11():1171. PubMed ID: 32733438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D.
    Al-Ahdal MN; Murugaiah V; Varghese PM; Abozaid SM; Saba I; Al-Qahtani AA; Pathan AA; Kouser L; Nal B; Kishore U
    Front Immunol; 2018; 9():1586. PubMed ID: 30105014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-β/SMAD2/3 signaling.
    Chen K; Cheng L; Qian W; Jiang Z; Sun L; Zhao Y; Zhou Y; Zhao L; Wang P; Duan W; Ma Q; Yang W
    Oncol Rep; 2018 Apr; 39(4):1573-1582. PubMed ID: 29484419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells.
    Liu F; Korc M
    Mol Cancer Ther; 2012 Oct; 11(10):2138-48. PubMed ID: 22869556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.
    Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T
    J Biol Chem; 2021; 296():100213. PubMed ID: 33779563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway.
    Jung DE; Kim JM; Kim C; Song SY
    Mol Carcinog; 2016 May; 55(5):633-45. PubMed ID: 25773908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD; Liu XE; Huang DS
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS; Choi KC; Hwang KA
    Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
    Zhu H; Qin H; Li DM; Liu J; Zhao Q
    Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer.
    Zong L; Chen K; Jiang Z; Chen X; Sun L; Ma J; Zhou C; Xu Q; Duan W; Han L; Lei J; Li X; Ma Q; Wang Z
    J Exp Clin Cancer Res; 2017 Dec; 36(1):181. PubMed ID: 29228980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
    Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
    Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of IGF/IGF-IR signaling pathway fails to induce epithelial-mesenchymal transition in pancreatic cancer cells.
    Kopantzev EP; Kopantseva MR; Grankina EV; Mikaelyan A; Egorov VI; Sverdlov ED
    Pancreatology; 2019 Mar; 19(2):390-396. PubMed ID: 30799278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signaling.
    Pei Z; Fu W; Wang G
    Biochem Biophys Res Commun; 2017 Nov; 493(1):455-460. PubMed ID: 28870807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
    Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
    J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.